Publications in collaboration with researchers from University College London (11)

2025

  1. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  2. Changes in Body Mass Index in Children and Adolescents Living with Human Immunodeficiency Virus in Europe and Thailand Starting Dolutegravir

    Open Forum Infectious Diseases, Vol. 12, Núm. 12

  3. Long-term non-progression in children with HIV: estimates from international cohort data

    AIDS, Vol. 39, Núm. 6, pp. 746-759

2024

  1. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration

    The Lancet HIV, Vol. 11, Núm. 10, pp. e660-e669

2022

  1. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

    Journal of the International AIDS Society, Vol. 25, Núm. 3

  2. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand

    Antiviral Therapy, Vol. 27, Núm. 3

2019

  1. Reduced Time to Suppression among Neonates with HIV Initiating Antiretroviral Therapy Within 7 Days after Birth

    Journal of Acquired Immune Deficiency Syndromes, Vol. 82, Núm. 5, pp. 483-490

2018

  1. Early and highly suppressive antiretroviral therapy are main factors associated with low viral reservoir in European perinatally HIV-infected children

    Journal of Acquired Immune Deficiency Syndromes

  2. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study

    PLoS Medicine, Vol. 15, Núm. 1

2017

  1. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: A multiregional analysis from Southern Africa, West Africa and Europe

    International Journal of Epidemiology, Vol. 46, Núm. 2, pp. 453-465

2008

  1. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

    Clinical Infectious Diseases, Vol. 46, Núm. 10, pp. 1601-1608